PL2309983T3 - Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę - Google Patents

Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę

Info

Publication number
PL2309983T3
PL2309983T3 PL09775591T PL09775591T PL2309983T3 PL 2309983 T3 PL2309983 T3 PL 2309983T3 PL 09775591 T PL09775591 T PL 09775591T PL 09775591 T PL09775591 T PL 09775591T PL 2309983 T3 PL2309983 T3 PL 2309983T3
Authority
PL
Poland
Prior art keywords
tetrahydrobiopterin
pharmaceutical form
pharmaceutical
Prior art date
Application number
PL09775591T
Other languages
English (en)
Inventor
Rudolf Widmann
Andreas Bernkop-Schnuerch
Original Assignee
Orpha Swiss Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orpha Swiss Gmbh filed Critical Orpha Swiss Gmbh
Publication of PL2309983T3 publication Critical patent/PL2309983T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL09775591T 2008-08-12 2009-08-07 Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę PL2309983T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT12542008 2008-08-12
EP09775591.2A EP2309983B1 (de) 2008-08-12 2009-08-07 Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin
PCT/AT2009/000306 WO2010017570A2 (de) 2008-08-12 2009-08-07 Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin

Publications (1)

Publication Number Publication Date
PL2309983T3 true PL2309983T3 (pl) 2019-09-30

Family

ID=41111155

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09775591T PL2309983T3 (pl) 2008-08-12 2009-08-07 Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę

Country Status (8)

Country Link
US (1) US20110144117A1 (pl)
EP (1) EP2309983B1 (pl)
JP (1) JP2011530540A (pl)
ES (1) ES2736730T3 (pl)
PL (1) PL2309983T3 (pl)
RU (1) RU2011109210A (pl)
TR (1) TR201910287T4 (pl)
WO (1) WO2010017570A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140108281A (ko) * 2013-01-10 2014-09-05 뉴트리셔널 테라퓨틱스, 인크. 건강 유지 및 급성 및 만성 장애의 치료를 위한 지질 보조제를 함유하는 츄어블 웨이퍼
DK2926805T3 (en) 2014-03-31 2016-07-25 Vasopharm Gmbh Solid pharmaceutical compositions comprising biopterine derivatives and uses of such compositions
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
KR102561697B1 (ko) * 2016-11-29 2023-07-28 피티씨 테라퓨틱스 엠피, 인크. 세피아프테린의 다형체 및 그의 염
JP2020532535A (ja) * 2017-09-01 2020-11-12 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンを含む医薬組成物及びその使用
DK3801536T3 (da) 2018-05-30 2024-08-19 Ptc Therapeutics Mp Inc Indgivelse af sepiapterin uden mad til anvendelse i en fremgangsmåde til at øge sepiapterinplasmaeksponering
US12257252B2 (en) 2018-05-30 2025-03-25 Ptc Therapeutics Mp, Inc. Compositions and methods for increasing tetrahydrobiopterin plasma exposure
JP7553906B2 (ja) * 2018-11-01 2024-09-19 宏 一瀬 Sprをコードするポリヌクレオチドを含む組換えベクター、及びそれを含む組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
CA2566433C (en) * 2004-05-11 2013-02-19 Daiichi Asubio Pharma Co., Ltd. Therapeutic agent for bh4-responsive hyperphenylalaninemia
US8003126B2 (en) * 2004-11-17 2011-08-23 Biomarin Pharmaceutical Inc. Stable tablet formulation
US20060188492A1 (en) * 2005-01-13 2006-08-24 Chronorx Llc, An Alaska Limited Liability Company Topical management of ocular and periocular conditions
CN101171005A (zh) * 2005-05-11 2008-04-30 尼科梅德有限责任公司 Pde4抑制剂罗氟司特与四氢生物蝶呤衍生物的组合
CA2682598C (en) * 2007-04-11 2016-06-07 Biomarin Pharmaceutical Inc. Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

Also Published As

Publication number Publication date
US20110144117A1 (en) 2011-06-16
JP2011530540A (ja) 2011-12-22
WO2010017570A2 (de) 2010-02-18
RU2011109210A (ru) 2012-09-20
EP2309983B1 (de) 2019-04-24
EP2309983A2 (de) 2011-04-20
TR201910287T4 (tr) 2019-07-22
WO2010017570A3 (de) 2010-08-05
ES2736730T3 (es) 2020-01-07

Similar Documents

Publication Publication Date Title
IL237391A0 (en) Pharmaceutical combination
IL228817A0 (en) Pharmaceutical compounds
GB0816372D0 (en) Pharmaceutical compounds
GB0801416D0 (en) Pharmaceutical compounds
IL207378A0 (en) Pharmaceutical solid state forms
LT2364137T (lt) Farmacinė suspensija
ZA201104348B (en) Pharmaceutical preparation
GB0816371D0 (en) Pharmaceutical compounds
GB0810615D0 (en) Novel pharmaceutical
GB0816370D0 (en) Pharmaceutical compounds
GB0806527D0 (en) Pharmaceutical compounds
IL208387A0 (en) Pharmaceutical composition
PL2309983T3 (pl) Farmaceutyczna postać podawania zawierająca tetrahydrobiopterynę
HU0800591D0 (en) Stable pharmaceutical combination
GB0815972D0 (en) Pharmaceutical preparation
IL208953A0 (en) Pharmaceutical combination
ZA201006224B (en) Pharmaceutical composition
GB2464200B (en) Pharmaceutical composition
GB0810617D0 (en) Novel pharmaceutical
GB0817969D0 (en) Pharmaceutical composition
HU0800414D0 (en) Pharmaceutical combination
GB0804486D0 (en) Novel pharmaceutical composituons
GB0813031D0 (en) Pharmaceutical formulations
GB0810217D0 (en) Pharmaceutical formulations
GB0802576D0 (en) Dosage form